Paul Tudor Jones profile

Paul Tudor Jones | Tudor Investment Corp Et Al

Fund Stats for Q1 2021Paul Tudor Jones is the managing partner of Tudor Investment Corp Et Al. The 13F filing for 2021 Q1 included $4.99B in managed 13F securities and a top 10 holdings concentration of 20.65%. Tudor Inves...

About Paul Tudor JonesPaul Tudor Jones II, founder and chief investment officer of Boston-based Tudor Investment Group, is one of the pioneers of the modern-day hedge fund industry. Jones began his career in the cotton pit...

Company
Ticker
Market Value
% Portfolio
Shares
Change
Chg. Shares
Quarter End Price
Current Price
Yearly High
Yearly Low
Market Cap
% Owned
SPY
309.74M
6.21%
781.51K
311.03%
591.38K
$396.33
$390.12
$479.98
$362.17
358.05B
0.09%
XLI
166.77M
3.35%
1.69M
New
1.69M
$98.45
$91.11
$107.88
$84.28
12.45B
1.24%
80.70M
1.62%
527.74K
58.30%
194.36K
$152.91
EMB
75.13M
1.51%
690K
New
690K
$108.88
$84.66
$112.71
$81.87
16.48B
0.35%
72.50M
1.45%
1.21M
6.65%
75.33K
$60.00
69.54M
1.39%
1.58M
New
1.58M
$44.03
LBRDK
68.94M
1.38%
459.11K
-0.00%
-9
$150.15
$91.71
$179.49
$91.14
14.09B
0.30%
64.56M
1.29%
422.20K
New
422.20K
$152.91
61.04M
1.22%
700K
926.65%
631.82K
$87.20
60.62M
1.22%
279.50K
New
279.50K
$216.90
ABNB
55.13M
1.11%
293.35K
-17.37%
-61.65K
$187.94
$125.04
$212.584
$86.71
79.96B
0.05%
SMH
53.36M
1.07%
219.10K
New
219.10K
$243.55
$203.00
$318.82
$189.94
2.37B
1.88%
49.43M
0.99%
750K
0
$65.91
ZM
49.08M
0.98%
152.77K
779.03%
135.39K
$321.29
$80.21
$291.31
$77.79
23.87B
0.05%
47.46M
0.95%
383.07K
377.69%
302.88K
$123.90
44.31M
0.89%
250.99K
4.58%
10.99K
$176.53
AAPL
44.02M
0.88%
360.40K
New
360.40K
$122.15
$152.37
$182.94
$129.04
2.50T
0.00%
SOXX
42.97M
0.86%
101.34K
-12.21%
-14.10K
$423.99
$352.06
$559.02
$326.7
2.69B
1.32%
42.59M
0.85%
440.09K
New
440.09K
$96.78
FXI
39.66M
0.80%
850K
New
850K
$46.66
$28.42
$42.7
$26.13
3.68B
0.66%

Holdings Breakdown

Legend
SPY
XLI
Alexion Pharmaceuticals Incorporated
EMB
Grubhub Inc
Navistar International Corporation
LBRDK
Alexion Pharmaceuticals Incorporated
Realpage Inc
Gw Pharmaceuticals -adr
ABNB
SMH
C3.ai Inc
ZM
Xilinx Incorporated
Varian Medical Systems Inc.
AAPL
SOXX
Ihs Markit Ltd
Other
Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.